Merck KGaA to replace two executives with company veterans
Adds details on executive board enlargement in last two paragraphs
FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA MRCG.DE said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but it added that its strategy remains unchanged.
Jean-Charles Wirth is to become the CEO of the Life Science unit, a maker of gear and supplies for biotech labs, succeeding Matthias Heinzel, who has decided to not renew his contract.
Wirth currently heads the Science & Lab Solutions subunit within Life Science, the company said in a statement.
Danny Bar-Zohar, currently the head of drug research and development, will become CEO of the pharmaceuticals division, succeeding Peter Guenter, who has decided to retire from Merck, it added.
In addition, Khadija Ben Hammada will assume the newly created role of Chief People Officer on March 1, as Merck adds a sixth executive board seat.
She currently holds the title of Chief Human Resources Officer and will take on additional responsibilities in areas such as sustainability, compliance and site management of the headquarters in Darmstadt.
Related Articles
Coca Cola (KO) Q4 Earnings Preview: Look for the Upside in the AI Initiatives, not in the Revenue and the EPS
Coca-Cola (KO) enters its fourth-quarter 2025 earnings call tomorrow with significant momentum. However, a fundamental shift is occurring.
Warsh’s Fed Era Signals a Death Knell for QE, Jolting the $30 Trillion Treasury Market
With Warsh’s nomination, his past proposals for governing the Federal Reserve are being brought to the forefront. A central issue is the formulation of a new "1951 Accord" to restructure the relationship between the Fed and the Treasury. Analysts suggest such a move could impact the $30 trillion Tre
Amazon Stock Predictions for 2026 to 2030: Will They Exceed Expectations and Achieve Major Long-Term Goals?
TradingKey - As we head into 2026, many investors are questioning where Amazon (AMZN) fits into the technology world.
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
